openPR Logo

Press Releases from mAb Biosimilars (2 total)

2017 Healthcare-Global mAb Biosimilars Market 2017 2020

"Global mAb Biosimilars Market 2017-2020" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- – About Biosimilars Biosimilars or follow-on biologics are generic versions of the biopharmaceutical products. These are developed following the patent expiry of an original molecule. Biosimilars have the same biological properties as original drugs and target the same diseases. They have many similarities but are not identical to the reference biopharmaceutical

Global MAb Biosimilars Market to grow at a CAGR of 4-7% during 2016-2020

About Biosimilars Biosimilars or follow-on biologics are generic versions of the biopharmaceutical products. These are developed following the patent expiry of an original molecule. Biosimilars have the same biological properties as original drugs and target the same diseases. They have many similarities but are not identical to the reference biopharmaceutical product. Technavios analysts forecast the spending on the global monoclonal antibody (mAb) biosimilars market to grow at a CAGR of 4-7% during

Go To Page:   1 2 3 4 5 6 7 8 9 10